Parex Resources Inc. (TSE:PXT – Get Free Report) Senior Officer Cam Grainger purchased 13,500 shares of the firm’s stock in a transaction dated Thursday, December 12th. The stock was bought at an average cost of C$13.45 per share, for a total transaction of C$181,575.00.
Parex Resources Stock Performance
Shares of PXT stock opened at C$13.75 on Friday. Parex Resources Inc. has a 12 month low of C$11.33 and a 12 month high of C$25.78. The company has a current ratio of 1.14, a quick ratio of 1.45 and a debt-to-equity ratio of 2.90. The company’s fifty day moving average price is C$13.91 and its 200-day moving average price is C$16.83. The stock has a market cap of C$1.39 billion, a PE ratio of 3.28, a price-to-earnings-growth ratio of 0.21 and a beta of 1.43.
Parex Resources Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Monday, December 16th will be issued a dividend of $0.385 per share. The ex-dividend date is Monday, December 9th. This represents a $1.54 annualized dividend and a dividend yield of 11.20%. Parex Resources’s payout ratio is 36.75%.
Analyst Ratings Changes
Read Our Latest Stock Analysis on PXT
Parex Resources Company Profile
Parex Resources Inc engages in the exploration, development, production, and marketing of oil and natural gas in Colombia. The company's principal land holdings and exploration blocks are in Colombia Llanos and Magdalena Basin. It has 55% working interest in Block LLA-34; 100% working interest in Cabrestero Block; and 50% working interest in Capachos Block and Block VIM-1.
Featured Articles
- Five stocks we like better than Parex Resources
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Insider Trading – What You Need to Know
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Parex Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parex Resources and related companies with MarketBeat.com's FREE daily email newsletter.